Health-related quality of life during treatment for renal cell carcinoma: results from a phase II study of axitinib

Author： Trask Peter C. Bushmakin Andrew G. Cappelleri Joseph C. Bycott Paul Liau Katherine Kim Sinil

ISSN： 0284-186X

Source： Acta Oncologica, Vol.47, Iss.5, 2008-11, pp. : 843-851

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

By Tsunoda Akira Yasuda Naokuni Nakao Kentaro Narita Kazuhiro Watanabe Makoto Matsui Nobuaki Tsunoda Yuko Kusano Mitsuo

International Journal of Clinical Oncology, Vol. 15, Iss. 3, 2010-06 ,pp. : 280-286

Springer Publishing Company

Access to resources Recommend Favorite

Axitinib in the treatment of metastatic renal cell carcinoma

By Ho Thai H Jonasch Eric

Future Oncology, Vol. 7, Iss. 11, 2011-11 ,pp. : 1247-1253

Future Medicine

Access to resources Recommend Favorite

By Miyake Hideaki

International Journal of Clinical Oncology, Vol. 18, Iss. 2, 2013-04 ,pp. : 220-225

Springer Publishing Company

Access to resources Recommend Favorite

By Osoba D. Brada M. Yung W.K.A. Prados M.D.

European Journal of Cancer, Vol. 36, Iss. 14, 2000-09 ,pp. : 1788-1795

Elsevier

Access to resources Recommend Favorite

Phase II trial of everolimus for the treatment of nonclear-cell renal cell carcinoma

By Koh Y. Lim H. Y. Ahn J. H. Lee J.-L. Rha S. Y. Kim Y. J. Kim T. M. Lee S.-H.

Annals of Oncology, Vol. 24, Iss. 4, 2013-04 ,pp. : 1026-1031

Oxford University Press

Access to resources Recommend Favorite